DE69705628D1 - Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat - Google Patents

Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat

Info

Publication number
DE69705628D1
DE69705628D1 DE69705628T DE69705628T DE69705628D1 DE 69705628 D1 DE69705628 D1 DE 69705628D1 DE 69705628 T DE69705628 T DE 69705628T DE 69705628 T DE69705628 T DE 69705628T DE 69705628 D1 DE69705628 D1 DE 69705628D1
Authority
DE
Germany
Prior art keywords
mometasonfuroat
preparations containing
medicinal preparations
free aerosol
chlorofluorocarbon
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69705628T
Other languages
English (en)
Other versions
DE69705628T2 (de
Inventor
Julianne Berry
A Sequeira
A Chaudry
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sharp and Dohme Corp
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of DE69705628D1 publication Critical patent/DE69705628D1/de
Application granted granted Critical
Publication of DE69705628T2 publication Critical patent/DE69705628T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/124—Aerosols; Foams characterised by the propellant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dispersion Chemistry (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Otolaryngology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69705628T 1996-08-29 1997-08-26 Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat Expired - Lifetime DE69705628T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70536896A 1996-08-29 1996-08-29
PCT/US1997/014708 WO1998008519A1 (en) 1996-08-29 1997-08-26 Chlorofluorocarbon-free mometasone furoate aerosol formulations

Publications (2)

Publication Number Publication Date
DE69705628D1 true DE69705628D1 (de) 2001-08-16
DE69705628T2 DE69705628T2 (de) 2002-05-08

Family

ID=24833161

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69705628T Expired - Lifetime DE69705628T2 (de) 1996-08-29 1997-08-26 Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat

Country Status (31)

Country Link
EP (1) EP0927037B1 (de)
JP (1) JP3264496B2 (de)
KR (1) KR100316358B1 (de)
CN (1) CN1162157C (de)
AR (1) AR008309A1 (de)
AT (1) ATE202936T1 (de)
AU (1) AU719079B2 (de)
BR (1) BR9711445A (de)
CA (1) CA2263905C (de)
CO (1) CO4900027A1 (de)
CZ (1) CZ294064B6 (de)
DE (1) DE69705628T2 (de)
DK (1) DK0927037T3 (de)
ES (1) ES2159148T3 (de)
GR (1) GR3036674T3 (de)
HK (1) HK1018206A1 (de)
HU (1) HU227915B1 (de)
ID (1) ID18137A (de)
IL (1) IL128714A (de)
MY (1) MY117377A (de)
NO (1) NO322528B1 (de)
NZ (1) NZ334112A (de)
PE (1) PE100198A1 (de)
PL (1) PL189036B1 (de)
PT (1) PT927037E (de)
SA (1) SA97180339B1 (de)
SK (1) SK282147B6 (de)
TR (1) TR199900379T2 (de)
TW (1) TW475901B (de)
WO (1) WO1998008519A1 (de)
ZA (1) ZA977668B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5874481A (en) * 1995-06-07 1999-02-23 Alliance Pharmaceutical Corp. Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
AR036358A1 (es) * 2001-08-28 2004-09-01 Schering Corp Un inhalador de dosis medidas que contiene una formulacion de suspension en aerosol para inhalacion, un proceso para la produccion de la formulacion, el producto y el uso de una formulacion para la manufactura de un medicamento de asma
CA2468958C (en) 2001-12-19 2012-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
GB0207906D0 (en) 2002-04-05 2002-05-15 3M Innovative Properties Co Formoterol and mometasone aerosol formulations
MXPA05002060A (es) * 2002-08-23 2005-06-08 Schering Corp Composiciones farmaceuticas.
EP1878664B1 (de) * 2002-08-27 2011-03-30 Schering Corporation Verfahren zur Herstellung von Formulierungen für Inhaliergeräte mit abgemessener Dosis
EP1925293A3 (de) * 2003-10-20 2010-01-13 Schering Corporation Pharmazeutische Aerosol-Zusammensetzungen
US20050136009A1 (en) * 2003-10-20 2005-06-23 Schering Corporation Pharmaceutical compositions
EP2117504A1 (de) * 2007-02-09 2009-11-18 Schering Corporation Stabile pharmazeutische wirkstoff-aerosole
CN107951893B (zh) * 2016-10-18 2022-04-26 天津金耀集团有限公司 一种糠酸莫米松粉吸入剂组合物
CN107961217B (zh) * 2016-10-18 2021-06-29 天津金耀集团有限公司 一种糠酸莫米松气雾剂组合物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5439670A (en) * 1989-11-28 1995-08-08 Riker Laboratories, Inc. Medicinal aerosol formulations
PT656207E (pt) * 1991-06-10 2001-11-30 Schering Corp Formulacoes de aerossois sem clorofluorocarbonetos
JPH06508149A (ja) * 1991-06-10 1994-09-14 シェリング・コーポレーション クロロフルオロカーボン不含エーロゾル製剤
PE44995A1 (es) * 1994-01-27 1995-12-18 Schering Corp Furoato de mometasona para el tratamiento de las enfermedades pulmonares y de las vias respiratorias

Also Published As

Publication number Publication date
HUP9902675A2 (hu) 2000-01-28
WO1998008519A1 (en) 1998-03-05
KR100316358B1 (ko) 2001-12-12
PL331828A1 (en) 1999-08-02
ID18137A (id) 1998-03-05
CA2263905A1 (en) 1998-03-05
NO990956L (no) 1999-04-28
PL189036B1 (pl) 2005-06-30
KR20000035879A (ko) 2000-06-26
HK1018206A1 (en) 1999-12-17
MY117377A (en) 2004-06-30
CA2263905C (en) 2002-05-14
NO990956D0 (no) 1999-02-26
IL128714A0 (en) 2000-01-31
PE100198A1 (es) 1999-01-11
SA97180339B1 (ar) 2006-01-31
AU4232997A (en) 1998-03-19
TW475901B (en) 2002-02-11
CZ294064B6 (cs) 2004-09-15
CZ63299A3 (cs) 1999-07-14
JP3264496B2 (ja) 2002-03-11
AU719079B2 (en) 2000-05-04
TR199900379T2 (xx) 1999-05-21
NZ334112A (en) 2000-07-28
BR9711445A (pt) 1999-08-24
ATE202936T1 (de) 2001-07-15
CO4900027A1 (es) 2000-03-27
IL128714A (en) 2003-05-29
ES2159148T3 (es) 2001-09-16
SK25399A3 (en) 1999-12-10
GR3036674T3 (en) 2001-12-31
AR008309A1 (es) 1999-12-29
EP0927037B1 (de) 2001-07-11
ZA977668B (en) 1998-02-26
JP2000503673A (ja) 2000-03-28
DE69705628T2 (de) 2002-05-08
HUP9902675A3 (en) 2000-02-28
CN1233960A (zh) 1999-11-03
PT927037E (pt) 2001-10-31
DK0927037T3 (da) 2001-09-24
NO322528B1 (no) 2006-10-16
SK282147B6 (sk) 2001-11-06
EP0927037A1 (de) 1999-07-07
CN1162157C (zh) 2004-08-18
HU227915B1 (en) 2012-05-29

Similar Documents

Publication Publication Date Title
DE69530325D1 (de) Aerosol-arzneiformulierungen
DE69831620D1 (de) Arzneizubereitungen enthaltend Kannabinoide
DE69800639T2 (de) Tetrahydrolipstatin enthaltende präparate
DE69814091D1 (de) Voriconazol-enthaltende pharmazeutische zubereitungen
FI973244A (fi) Farmaseuttisia valmisteita nenänsisäiseen käyttöön
NO954146D0 (no) Belagte farmasöytiske preparater
ATE373465T1 (de) Aerosolzubereitungen
DE69723202D1 (de) Inhalatoren
IT1293803B1 (it) Formulazioni di aerosol medicinali
NO993868D0 (no) 3-piperidyl-4-oksokinazolin-derivater og medisinske preparater som inneholder slike
PT932397E (pt) Formulacoes em aerossol medicinais compreendendo budesonida
DE69705628D1 (de) Chlorfluorkohlenwasserstoff freie aerosol-arzneizubereitungen enthaltend mometasonfuroat
KR960016892A (ko) 약제의 신독성 경감제
DE59707298D1 (de) Desodorierende zubereitungen
DK0925273T3 (da) Farmaceutiske præparater indeholdende 4-oxo-butansyrer
IS5062A (is) Lyfjablöndur sem innihalda afleiður N-súlfonýlindólíns
DK0826679T3 (da) Naphthylforbindelser og -præparater
DE69722433D1 (de) Pharmazeutische zubereitungen, welche zidovudin und lamivudine enthalten
EE03511B1 (et) Misolastiini sisaldavad prolongeeritud toimega farmatseutilised preparaadid
SE9600141D0 (sv) Pharmaceutical formulation
DK0859635T3 (da) Stabiliserede farmaceutiske præparater indeholdende dobutamin
IS1603B (is) Einnota úðatæki
ZA976038B (en) Medicinal aerosol solution formulation
SE9404195D0 (sv) New pharmaceutical formulation
SE9502452D0 (sv) Aerosol formulations

Legal Events

Date Code Title Description
8364 No opposition during term of opposition